SPY—
QQQ—
DIA—
NVDA—
AAPL—
TSLA—
MSFT—
BTC-USD—
15-min delayed
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

MapLight Therapeutics, Inc. Common Stock

MPLT XNAS
$5.94 -0.48 (-7.48%) ▼ 15-min delayed
Open
$6.33
High
$6.48
Low
$5.92
Volume
357.9K
Market Cap
$333.87M

About MapLight Therapeutics, Inc. Common Stock

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 133 Website →

Related Market News

No specific coverage for MPLT yet. Check out our latest market news or earnings calendar.

Get MPLT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on MapLight Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.